Paratek Pharmaceuticals, Inc.
PRTKDelisted Sep 21, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001178711
Paratek Pharmaceuticals, Inc. was delisted on Sep 21, 2023; its insiders filed their last Form 4 on Sep 21, 2023; 66 institutions reported holding it in 13F filings for Q2 2023, worth $47.0M in total; no superinvestor held it.
Q1 2023 vs. Q4 2022
How the institutions holding Paratek Pharmaceuticals, Inc. changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Of which not filed for Q1 2023 | Q1 2023 | Change |
|---|---|---|---|---|
| Holders | 76 | 2 | 63 | −11 |
| Shares | 22.8M | 1.52M | 23.3M | +2.03M (+9.6%) |
| Value | $42.6M | $2.85M | $59.1M | +$19.4M (+48.8%) |
2 institutions that held it in Q4 2022 haven't filed for Q1 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (7)
Institutions that held Paratek Pharmaceuticals, Inc. at the end of Q1 2023 but not at the end of Q4 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Carlyle Group Inc. | 1,041,131 | $2.62M | 0.08% |
| Eversept Partners, LP | 638,474 | $1.62M | 0.15% |
| Virtu Financial LLC | 18,192 | $46.0K | 0.00% |
| Cutter & CO Brokerage, Inc. | 10,900 | $27.7K | 0.01% |
| Kingsview Wealth Management, LLC | 10,000 | $25.4K | 0.00% |
| Baader Bank INC | 11,580 | $22.9K | 0.00% |
| Northwestern Mutual Wealth Management Co | 100 | $254 | 0.00% |
Sold out (18)
Institutions that held Paratek Pharmaceuticals, Inc. at the end of Q4 2022 and filed for Q1 2023 without it.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Citadel Advisors LLC | 203,159 | $379.9K |
| XTX Topco Ltd | 80,387 | $150.3K |
| Marshall Wace, LLP | 43,952 | $82.2K |
| Natixis | 29,006 | $54.2K |
| Ergoteles LLC | 26,601 | $49.7K |
| Mackenzie Financial Corp | 21,970 | $41.1K |
| Prudential Financial Inc | 20,900 | $39.1K |
| Jump Financial, LLC | 19,844 | $37.1K |
| Verition Fund Management LLC | 19,766 | $37.0K |
| Mirabella Financial Services LLP | 17,544 | $32.8K |
| Occudo Quantitative Strategies LP | 15,722 | $29.4K |
| Simplex Trading, LLC | 15,716 | $29.0K |
| BNP Paribas Arbitrage, SA | 12,817 | $24.0K |
| Two Sigma Securities, LLC | 12,575 | $23.5K |
| Quantbot Technologies LP | 6,600 | $12.3K |
| Silverback Asset Management LLC | 986 | $1.84K |
| Key Financial Inc | 475 | $1.22K |
| Citigroup Inc | 2 | $4 |
Not filed for Q1 2023 yet (2)
Institutions that held Paratek Pharmaceuticals, Inc. at the end of Q4 2022 and haven't filed a 13F for Q1 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Abingworth LLP | 1,041,131 | $1.95M |
| Telemetry Investments, L.L.C. | 483,000 | $903.0K |